Invention Grant
US09278106B2 Compositions for oral administration of zoledronic acid or related compounds for treating ankylosing spondylitis
有权
用于口服施用唑来膦酸或相关化合物用于治疗强直性脊柱炎的组合物
- Patent Title: Compositions for oral administration of zoledronic acid or related compounds for treating ankylosing spondylitis
- Patent Title (中): 用于口服施用唑来膦酸或相关化合物用于治疗强直性脊柱炎的组合物
-
Application No.: US14279213Application Date: 2014-05-15
-
Publication No.: US09278106B2Publication Date: 2016-03-08
- Inventor: Herriot Tabuteau
- Applicant: Antecip Bioventures II LLC
- Applicant Address: US NY New York
- Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee Address: US NY New York
- Agency: K&L Gates LLP
- Agent Louis C. Cullman; Brent A. Johnson
- Main IPC: A61K31/663
- IPC: A61K31/663 ; A61K31/675 ; A61K9/20 ; A61K9/00 ; A61K9/28
Abstract:
Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailabilty of zoledronic acid can be enhanced by administering the zoledronic acid in the disodium salt form.
Public/Granted literature
Information query
